ARTICLE | Financial News
Adolor raises $60 million
May 30, 2001 7:00 AM UTC
ADLR raised $60 million in a private placement with existing institutional investors. The company is in Phase III testing of its ADL 8-2698 oral gastrointestinal-restricted opioid receptor antagonist ...